Galera Therapeutics Inc (GRTX) financials · P/E 0.1, $17.3M cap
Galera Therapeutics Inc (GRTX) P/E 0.1, $17.3M cap.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| Net Income | -$19.0M | -$59.1M | -$62.2M | -$80.5M |
| EPS (Diluted) | $-0.34 | $-1.33 | $0.00 | $0.00 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $10.1M | $26.1M | $44.0M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $8.3M | $18.3M | $4.3M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $153.8M | $157.3M | $153.2M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Cash Flow | -$12.1M | -$44.8M | -$43.4M | -$68.0M |
| CapEx | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$46.0K | $27.3M | $24.0M | $5.2M |
| Financing Cash Flow | $2.2M | $31.5M | $3.9M | $66.7M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |
FAQ
What is GRTX P/E and revenue?
Galera Therapeutics Inc (GRTX) P/E 0.1, $17.3M cap.
What is GRTX revenue?
Galera Therapeutics Inc last cached revenue is $0 (FY2024).
Is GRTX profitable?
Galera Therapeutics Inc last cached net income is -$19.0M.
What are GRTX total assets?
Galera Therapeutics Inc last cached total assets are $10.1M.
What is GRTX free cash flow?
Galera Therapeutics Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.